RE: APOLOGY3 Jul 2023 12:52
Postman Pork’s or the prof it’s a simple answer
Dr Adam Hargreaves (PathCelerate Limited)LinkedIn
Dr. Adam Hargreaves is the founder of PathCelerate Limited, a contract research drug efficacy and safety company. Spanning a 20 year career, he previously worked for AstraZeneca, and has interests and skills in preclinical and translational small molecule, biologic, and RNA-based pharmaceuticals. PathCelerate has provided preclinical and clinical drug discovery and development assistance to the majority of the global top 20 pharmaceutical companies, in addition to a wide and diverse range of small- and medium-sized biotechnology and medical device firms; assisting in the generation of numerous Investigational New Drug and Clinical Trial Application submissions.
Adam is a Fellow of the Royal College of Pathologists, and is a board-certified Diplomate of the American College of Veterinary Pathology. He has a PhD in oncology medicine safety and is a visiting Professor at the University of Surrey, where he lectures in pharmaceutical toxicology.